Vermillion Wealth Management, Inc.
Position in TGTX — Tg Therapeutics, Inc.
CIK 1737012
ROSEMOUNT, MN
Position in TGTX
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$27,470
+$10,860 QoQ
Shares Held
500
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#352
of 420 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vermillion Wealth Management, Inc. holds $68,753 across 7 Biotechnology names. TGTX ranks #1 (40.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TGTX |
Tg Therapeutics, Inc.
This page
|
500 | $27,470 | |
| 2 | CAI |
Caris Life Sciences, Inc.
|
1,000 | $17,820 | |
| 3 | SMMT |
Summit Therapeutics Inc.
|
1,000 | $14,570 | |
| 4 | AVXL |
Anavex Life Sciences Corp.
|
2,000 | $5,180 | |
| 5 | CELC |
Celcuity Inc.
|
20 | $2,092 | |
| 6 | TNYA |
Tenaya Therapeutics, Inc.
|
1,500 | $1,108 | |
| 7 | RXRX |
Recursion Pharmaceuticals, Inc.
|
140 | $513 |
All Filings in TGTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,470 | 500 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $16,610 | 500 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $29,810 | 1,000 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $36,125 | 1,000 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $35,990 | 1,000 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $39,430 | 1,000 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $30,100 | 1,000 | Shares | Sole | 2025-02-21 | |
| No filing history on record for this holder in this stock. | ||||||